CAR T-cell rebate.

You can get a huge one according to this economic analysis in terms of price per year of life saved when CAR T-cells are used on pediatric patients, who have a 40% chance of cure at potentially very young ages all in contrast to adults. You do the math. | Whittington, JAMA Pediat 2017